Alexion Pharmaceuticals, Inc.

We’re seeking talented individuals who are driven to push the boundaries of scientific discovery and bring life-changing therapies to those in need. If you’re ready to be part of a dynamic team that committed to making a difference, apply now: http://spr.ly/6045YuN7D

Patient centricity isn’t a buzzword for us — it’s embedded in our DNA. Learn from several of our colleagues as they discuss how we act with a sense of urgency and intention to help address patient barriers. #LifeAtAlexion

Why is conducting #ClinicalTrials for rare diseases difficult? Because studying a #RareDisease poses unique challenges and requires outside-of-the-box thinking. Watch the video to learn why the need for transformative medicines is great for those living with rare diseases.

Curious about #LifeAtAlexion? Our Director of Global Medical Sciences Katherine Garlo shares how our commitment to bringing together diverse perspectives creates a positive and thriving workplace.

While #RareDiseases can impact individuals of any age, they affect more children than you might think – in fact, 50% of those diagnosed with a rare disease are children. Share this post to raise awareness and education for children impacted by rare diseases around the world.

As part of our commitment to improving outcomes for people living with rare neurological diseases, we are proud that our work with European Federation of Neurological Associations and other global stakeholders has enabled the development of The Rare Neurology Charter. These disorders are currently the third leading cause of disability and premature death, and as the EU moves into a new legislative term, we look forward to the opportunity to address the needs of the estimated 500,000+ people living with rare neurological disorders in Europe. Sign the Call to Action today and show your support for the development of action plans to aid EU policy change for rare neurological diseases: http://spr.ly/6046codUr

Raj Pradhan, PhD joined Alexion because he was inspired by the mission to find solutions for devastating conditions that have few or no available treatment options. In this video, he explains the challenges that motivate him to follow the science, every single day. #LifeAtAlexion

At Alexion, every team member plays a crucial role in advancing our mission to serve patients in need. Are you driven by purpose and ready to make a difference for the #RareDisease community? Explore our job openings and join our team today: http://spr.ly/6047im3PR

Today, AstraZeneca completed the acquisition of Amolyt Pharma, a global biopharmaceutical company focused on developing novel treatments for rare endocrine diseases. This acquisition bolsters the Alexion, AstraZeneca Rare Disease pipeline and expands on its bone metabolism franchise as we work to serve more #RareDisease patients around the world.

For those living with #RareDiseases, the path to diagnosis can feel like an endless odyssey, marked by countless challenges. Millions navigate a maze of misdiagnoses, unanswered questions, and relentless uncertainty. We’re hoping to change that through education and awareness.